Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Nortis Inc See All Filings	D	2022-08-10 15:48:11 UTC
Amount To Be Raised $9,500,000 Associated Brokers / Dealers N/A CIK Number 0001416214 Filed Document 0001416214-22-000002 Exclusions or Exemptions 506b Accepted Date 2022-08-10 15:48:11 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Nortis Inc See All Filings	D	2022-01-10 10:28:49 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0001416214 Filed Document 0001416214-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-01-10 10:28:49 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Debt
Nortis Inc See All Filings	D	2021-06-15 09:37:29 UTC
Amount To Be Raised $1,000,000 Associated Brokers / Dealers N/A CIK Number 0001416214 Filed Document 0001416214-21-000003 Exclusions or Exemptions 506b Accepted Date 2021-06-15 09:37:29 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Debt
Nortis Inc See All Filings	D	2021-06-15 09:33:32 UTC
Amount To Be Raised $1,500,000 Associated Brokers / Dealers N/A CIK Number 0001416214 Filed Document 0001416214-21-000002 Exclusions or Exemptions 506b Accepted Date 2021-06-15 09:33:32 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Nortis Inc See All Filings	D/A	2017-07-18 14:35:04 UTC
Amount To Be Raised $500,000 Associated Brokers / Dealers N/A CIK Number 0001416214 Filed Document 0001416214-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-07-18 14:35:04 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Nortis Inc See All Filings	D/A	2017-06-29 18:42:29 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001416214 Filed Document 0001416214-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-06-29 18:42:29 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Debt
Nortis Inc See All Filings	D	2016-08-05 14:59:41 UTC
Amount To Be Raised $500,000 Associated Brokers / Dealers N/A CIK Number 0001416214 Filed Document 0001416214-16-000004 Exclusions or Exemptions 506b Accepted Date 2016-08-05 14:59:41 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Nortis Inc See All Filings	D	2016-06-30 15:49:14 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001416214 Filed Document 0001416214-16-000003 Exclusions or Exemptions 506b Accepted Date 2016-06-30 15:49:14 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Debt
Nortis Inc See All Filings	D	2015-03-13 00:00:00 UTC
Amount To Be Raised $3,399,999 Associated Brokers / Dealers N/A CIK Number 0001416214 Filed Document 0001416214-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-03-13 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Nortis Inc See All Filings	D	2014-07-02 00:00:00 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001416214 Filed Document 0001416214-14-000002 Exclusions or Exemptions 506b Accepted Date 2014-07-02 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Nortis Inc See All Filings	D/A	2014-03-25 00:00:00 UTC
Amount To Be Raised $1,500,000 Associated Brokers / Dealers N/A CIK Number 0001416214 Filed Document 0001416214-14-000001 Exclusions or Exemptions 506b Accepted Date 2014-03-25 00:00:00 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity